9 April 2018
DPUK strengthens its collaboration as the University of Exeter joins the public-private partnership, furthering dementia research by drawing on the distinct power of cohort studies.
22 March 2018
DPUK researchers will present the results of their work with US colleagues in a joint symposium in Washington D.C. today, highlighting how DPUK enables international research collaborations.
20 March 2018
DPUK is delighted to have a big presence at the Alzheimer’s Research UK conference in London this year. See DPUK scientists present a broad range of new developments and findings in the poster exhibition and come and visit us at our stand. If you can't be there, stay tuned on Twitter – we'll be sharing our updates and insights throughout the programme.
21 February 2018
Invicro becomes the seventh industry partner to join Dementias Platform UK, contributing expertise in brain imaging to further our aim to accelerate treatments for dementia.
22 January 2018
DPUK launches its Data Discovery Awards. Individual research grants of up to £50k are available for the best research proposals using the Data Portal.
8 December 2017
Following the launch of the new Data Portal, DPUK experts will be answering your questions LIVE on Twitter. The Twitter Q & As will be taking place on 11 December at 1pm GMT and 21 December at 4pm GMT, using the hashtag #DPUKportal
16 November 2017
Dementias Platform UK is delighted to announce the launch of a new and improved version of its pioneering Data Portal, and encourages scientists to access the data as soon as they can.
3 October 2017
Cambridge Cognition and NeuroVision Imaging become associate partners of Dementias Platform UK through their involvement in the Deep and Frequent Phenotyping (DFP) study.
21 September 2017
On World Alzheimer's Day, Catherine Moody, Programme Manager for dementias initiatives at the UK Medical Research Council, takes a fresh look at the dementias research landscape and where Dementias Platform UK and the cohort studies fit in.
13 July 2017
DPUK scientists across a range of disciplines, many of whom are closely involved in the development of the portal tools, are looking forward to meeting delegates of this year’s Alzheimer’s Association International Conference (AAIC) at the DPUK stand.
27 June 2017
Professors Clare Mackay and Simon Lovestone were interviewed by BBC World at One about research into the early signs of Alzheimer's.
20 May 2017
An ambitious, multicentre research programme into Vascular Dementia, led by DPUK scientists, is due to start later this year following confirmation of £1.2 million funding by Stroke Association, British Heart Foundation, Alzheimer's Society and Dementias Platform UK.
30 April 2017
To better understand and treat the diseases that cause dementia, researchers rely on volunteers who, year on year, undergo a variety of medical tests. Now, for the first time, anonymised biological, lifestyle, and behaviour data collected from these medical volunteers is accessible in the Dementias Platform UK data portal – an online resource for disease researchers across many different disciplines.
7 March 2017
For the first of a new series, Clare Mackay shares her journey to becoming a Professor and her involvement with DPUK. Clare Mackay is Professor of Imaging Neuroscience at University of Oxford and leads on imaging informatics for Dementias Platform UK.
4 October 2016
King’s College London becomes the 11th Academic Partner to join Dementias Platform UK
3 October 2016
Early Career Researcher Norah Epie invited Professor Diana Kuh for an interview so that we could learn more about how she achieved her various academic successes, the route she took to becoming a Professor, and the training and support she received during her career.
22 August 2016
The MRC Neurosciences Board and the National Institute of Health Research (NIHR) have today announced a multi-million pound award to Professor Simon Lovestone, Oxford. The award, made as part of the Dementias Platform UK, is for a Deep and Frequent Phenotyping Study, designed to detect early signs of Alzheimer’s disease. It aims to significantly increase our understanding of how to detect early Alzheimer’s disease.